A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation

A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation

Abstract SCN5A gene mutations are described in 2% of patients with dilated cardiomyopathy (DCM) and different rhythm disturbances, including multifocal ectopic Purkinje‐related premature contractions. Recent data indicate that sodium channel blockers are particularly effective monotherapy in carrier...

Full description

Bibliographic Details
Main Authors: Joanna Zakrzewska‐Koperska, Zofia T. Bilińska, Grażyna T. Truszkowska, Maria Franaszczyk, Waldemar Elikowski, Grzegorz Warmiński, Katarzyna Kalin, Piotr Urbanek, Robert Bodalski, Michał Orczykowski, Łukasz Szumowski, Rafał Płoski, Maria Bilińska
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:ESC Heart Failure
Subjects:
R814W SCN5A variant
Arrhythmogenic dilated cardiomyopathy
Multifocal ectopic Purkinje‐related premature contractions
Online Access:https://doi.org/10.1002/ehf2.12993

Internet

https://doi.org/10.1002/ehf2.12993

Similar Items